Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5. This indicates a newer version of the page, likely reflecting a minor update rather than substantive changes to study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a new revision label, v3.6.4, replacing the previous v3.6.3. This appears to be a behind-the-scenes platform update rather than a change to the study content shown on the page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe page's Revision value was updated from v3.6.0 to v3.6.3, replacing the previous version. This indicates that a newer page/template version is now in use for the study record.SummaryDifference0.1%

- Check61 days agoChange DetectedNew user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status line ("No longer looking for participants") have been added, and the Intervention/Treatment heading formatting has been updated. The revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check69 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new build of the page. This appears to be a minor software/UI update with no changes to the study content or eligibility.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating a deployed update to the site’s software. This update does not modify study details or data presented on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.